Drug Recall
Terminated
Historical recordClass II
Pyridoxine 100mg/ml Inj MDV, 1X30 ml 30 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Meperidine 100mg/ml MDV, 5ml 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Lidocaine 2% Inj MDV, 20 ml 30 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
M.I.C.+B12 Inj MDV: 3x50ml, 4x50 ml 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Glutathione 200mg/ml Inj SDV: 3x50ml 14 day expiration, 1x50ml 21 day expiration
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Gentamicin 24mg/60ml Irrigation, 15x60ml Syr Irrigation, 14 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Hydroxyprogesterone Inj 250mg/ml MDV, 5 ml Intramuscular, 30 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Methylcobalamin Inj 25mg/ml Syr: 8x0.06mlsyr, 10x0.06 ml syr, 12x0.06 ml syr Subcutaneous, 30 and 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Methylcobalamin Inj 2.5mg/ml MDV, 10 ml Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Methylcobalamin 5mg/ml Inj Syr, 10x0.4syr Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Methylcobalamin Inj 5mg/ml MDV: 5 ml, 10 ml, 12 ml, 20 ml Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Methylcobalamin Inj 1mg/ml MDV, 10 ml, 15 ml, 20 ml, 30 ml, 4x30 ml Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Hydroxycobalamin Inj 2500 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Hydroxycobalamin Inj 1 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Hydroxycobalamin Inj 1000mcg/ml MDV: 10 ml, 15 ml, 20 ml, 30 ml Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
HCG Inj 500un/ml MDV, 5 ml Subcutaneous, 30 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
HCG Inj 1250 un/ml MDV, 4 ml Subcutaneous, 30 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
HCG Inj 1200un/ml MDV, 10 ml Subcutaneous, 30 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
HCG Inj 1000un/ml MDV: 4ml, 8 ml Subcutaneous, 30 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Folic Acid Inj 5mg/ml MDV, 10 ml Subcutaneous, 90 day expiration,
by Nora Apothecary and Alternative Therapies, Inc.
- Reason
- Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- Recall initiated
- April 22, 2013
- Reported by FDA
- June 5, 2013
- Distribution
- Nationwide
View recall →
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer.